Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure

Langley, 2000, Why a pomegranate?, BMJ, 321, 1153, 10.1136/bmj.321.7269.1153

Narr Ben, 1996, Quantitative determination of the polyphenolic content of pomegranate peel, Z Lebensm Unters Forsch, 203, 374, 10.1007/BF01231077

Gil MI, Tomas-Barberan FA, Hess-Pierce B, Holcroft DM, Kedar AA. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing, J Agric Food Chem 2000;10:4581–9.

Aviram, 2000, Pomegranate juice consumption reduces oxidative stress, low density lipoprotein modifications and platelet aggregation: studies in the atherosclerotic apolipoprotein E deficient mice and in humans, Am J Clin Nutr, 71, 1062, 10.1093/ajcn/71.5.1062

Aviram, 1999, Does paraoxonase play a role in susceptibility to cardiovascular disease?, Mol Med Today, 5, 381, 10.1016/S1357-4310(99)01546-4

Alderman, 1991, Association of the rennin–sodium profile with the risk of myocardial infarction in patients with hypertension, N Engl J Med, 324, 1098, 10.1056/NEJM199104183241605

Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 327, 669, 10.1056/NEJM199209033271001

Colins, 1990, Blood pressure, stroke and coronary heart disease. Short-term reduction in blood pressure: overview of randomized drug trials epidemiological content, Lancet, 335, 827

Dzau, 1988, Circulating versus local renin-angiotensin system in cardiovascular homeostasis, Circulation, 77, 14

Griendling, 1989, Angiotensin II stimulation of vascular smooth muscle cells, J Cardiovasc Pharmacol, 14, S27, 10.1097/00005344-198900146-00008

Keidar, 1994, Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II, Atherosclerosis, 107, 71, 10.1016/0021-9150(94)90143-0

Kowala, 1994, Inhibitors of angiotensin-converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids, Atherosclerosis, 108, 61, 10.1016/0021-9150(94)90037-X

Chobanian, 1990, Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit, Hypertension, 15, 327, 10.1161/01.HYP.15.3.327

Rolland, 1991, Angiotensin converting enzyme inhibition-induced changes in patterns of hemodynamics, aorta viscoelasticity, arterial histopathology and endothelial cholesterol fluxes of atherosclerotic minipigs, J Hypertens, 9, S178, 10.1097/00004872-199112000-00073

Duffy, 1999, Treatment of hypertension with ascorbic acid, Lancet, 354, 2048, 10.1016/S0140-6736(99)04410-4

Galley, 1997, Combination oral antioxidant supplementation reduces blood pressure, Clin Sci, 92, 361, 10.1042/cs0920361

Singh, 1999, Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease, J Hum Hypertens, 13, 203, 10.1038/sj.jhh.1000778

Narr Ben, 1996, Quantitative determination of the polyphenolic content of pomegranate peel, Z Lebensm Unters Forsch, 203, 374, 10.1007/BF01231077

Kitiyakara, 1998, Antioxidants for hypertension, Curr Opin Nephrol Hypertens, 7, 531, 10.1097/00041552-199809000-00008

He, 1998, Inactivation of cytochrome P-450 3A4 by bergamottin, a component of grapefruit juice, Chem Res Toxicol, 11, 252, 10.1021/tx970192k

Keidar, 2000, Attenuation of atherosclerosis in apolipoprotein E deficient mice Ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin, J Cardiovasc Pharmacol, 35, 64, 10.1097/00005344-200001000-00008

Scheen, 1999, The HOPE study: demons the cardiovascular protection of Ramipril, a ACE inhibitor, Rev Med Liege, 54, 835